Neuropathix_Logo_wTag.png
Neuropathix, Inc. CEO Recaps 2020 Advances and Potential Ahead
January 25, 2021 09:00 ET | Neuropathix, Inc.
DOYLESTOWN, Pa., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (“Neuropathix” or the “Company”) (OTCQB: NPTX), a socially responsible pain management life sciences company, announced today...
The Next Generation of Innovative Immunotherapy Agents, Inflammasome Inhibitors, Will Be Addressed in Panel Discussion on Monday, Feb. 17, 2020, at 10 a.m. EST
January 10, 2020 11:50 ET | Noble Capital Markets, Inc.
FORT LAUDERDALE, Fla., Jan. 10, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Noble Capital Markets, Inc. (“Noble”) announced it has assembled a panel of scientists and experienced life science...